JAMA flags unapproved GLP-1 drugs sold without regulation, pointing to unknown contents and safety concerns for buyers chasing cheaper shots.
Recap by typeshit. Post by JAMA on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
A personal week two check-in from someone documenting their tirzepatide journey, with 2 pounds lost in the latest week.
General fall reminders from the app Healthi about regular meals, hydration and movement while on a GLP-1. Generic wellness tips.
Loading…